期刊的影响因子--文章列表

期刊文章列表
Dong Liang，Chen Yu，Zhao Ma，Xingye Yang，Zhenzhen Li，Xuhui Dong，Xiaojun Qin，Lupei Du，Minyong Li（Key Laboratory of Chemical Biology （MOE），School of Pharmaceutical Sciences，Cheeloo College of Medicine，Shandong University）.Identification of anthelmintic parbendazole as a therapeutic molecule for HNSCC through connectivity map-based drug repositioning[J].Acta Pharmaceutica Sinica B,2022,第5期 Di Zhu^1,2，Yu Lu^1,2，Lin Gui^1,2，Wenjing Wang³，Xi Hu⁴，Su Chen⁵，Yanming Wang⁶，Yuji Wang^1,2（Department of Medicinal Chemistry，College of Pharmaceutical Sciences of Capital Medical University；Beijing Area Major Laboratory of Peptide and Small Molecular Drugs，Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China，Beijing Laboratory of Biomedical Materials；Beijing Institute of Hepatology，Beijing Youan Hospital，Capital Medical University；Quantum Design China Ltd.，Universal Business Park；Laboratory of Biomaterials and Biomechanics，Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction，School of Stomatology，Capital Medical University；School of Life Sciences，Henan University）.Self-assembling, pH-responsive nanoflowers for inhibiting PAD4 and neutrophil extracellular trap formation and improving the tumor immune microenvironment[J].Acta Pharmaceutica Sinica B,2022,第5期 Lihuan Shang¹，Xue Jiang^1,2，Ting Yang¹，Hongbo Xu¹，Qi Xie¹，Mei Hu¹，Conglian Yang¹，Li Kong¹，Zhiping Zhang^1,3,4（Tongji School of Pharmacy，Huazhong University of Science and Technology；Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation，Medical Research Center，Sun Yat-sen Memorial Hospital，Sun Yat-sen University；National Engineering Research Center for Nanomedicine，Huazhong University of Science and Technology；Hubei Engineering Research Centre for Novel Drug Delivery System，Huazhong University of Science and Technology）.Enhancing cancer chemo-immunotherapy by biomimetic nanogel with tumor targeting capacity and rapid drug-releasing in tumor microenvironment[J].Acta Pharmaceutica Sinica B,2022,第5期 Sifan Yu^1,2，Dijie Li^1,2,3，Ning Zhang⁴，Shuaijian Ni^1,2,3，Meiheng Sun^1,2,3，Luyao Wang^1,2,3，Huan Xiao⁴，Dingdong Liu^1,2,3，Jin Liu^1,2,3，Yuanyuan Yu^1,2,3，Zongkang Zhang⁴，Samuel Tin Yui Yeung¹，Shu Zhang⁵，Aiping Lu^1,2,3，Zhenlin Zhang⁶，Baoting Zhang⁴，Ge Zhang^1,2,3（Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases，School of Chinese Medicine，Hong Kong Baptist University；Institute of Integrated Bioinfomedicine and Translational Science，School of Chinese Medicine，Hong Kong Baptist University；Institute of Precision Medicine and Innovative Drug Discovery，HKBU Institute for Research and Continuing Education；School of Chinese Medicine，Faculty of Medicine，the Chinese University of Hong Kong；The Key Laboratory of Aerospace Medicine，Ministry of Education，Air Force Medical University；Shanghai Clinical Research Center of Bone Disease，Department of Osteoporosis and Bone Diseases，Shanghai Jiao Tong University Affiliated Sixth People's Hospital）.Drug discovery of sclerostin inhibitors[J].Acta Pharmaceutica Sinica B,2022,第5期 Xiaoling Chen¹，Jingliang Zhang¹，KeWei Wang²（Department of Molecular and Cellular Pharmacology，State Key Laboratory of Natural and Biomimetic Drugs，School of Pharmaceutical Sciences，Peking University；Department of Pharmacology，Qingdao University School of Pharmacy）.Inhibition of intracellular proton-sensitive Ca²⁺-permeable TRPV3 channels protects against ischemic brain injury[J].Acta Pharmaceutica Sinica B,2022,第5期 Jie Chang^1,2，Ruirui Yang^2,3,4，Lifan Chen^2,3，Zisheng Fan^1,2，Jingyi Zhou^1,2，Hao Guo^2,3，Yinghui Zhang^2,3，Yadan Liu^1,2，Guizhen Zhou^1,2，Keke Zhang^1,2，Kaixian Chen^2,3,1，Hualiang Jiang^2,3,1,4，Mingyue Zheng^2,3,1，Sulin Zhang^2,3（School of Chinese Materia Medica，Nanjing University of Chinese Medicine；Drug Discovery and Design Center，State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；University of Chinese Academy of Sciences；Shanghai Institute for Advanced Immunochemical Studies，and School of Life Science and Technology，ShanghaiTech University）.Discovery of ARF1-targeting inhibitor demethylzeylasteral as a potential agent against breast cancer[J].Acta Pharmaceutica Sinica B,2022,第5期 Siping Liang¹，Jiaying Li²，Zhengyu Zou¹，Miao Mao³，Siqi Ming¹，Fan Lin³，Ziyan Zhang³，Can Cao¹，Jinyu Zhou¹，Yuanqing Zhang³，Jiaping Li⁴，Minhao Wu¹（Zhongshan School of Medicine，Sun Yat-sen University；Department of Laboratory Medicine，Guangdong Second Provincial General Hospital；Guangdong Key Laboratory of Chiral Molecule and Drug Discovery，School of Pharmaceutical Sciences，Sun Yatsen University；Department of Interventional Oncology，The First Affiliated Hospital，Sun Yat-sen University）.Tetrahedral DNA nanostructures synergize with MnO₂ to enhance antitumor immunity via promoting STING activation and M1 polarization[J].Acta Pharmaceutica Sinica B,2022,第5期 Youbo Zhang^1,2，Tingting Yan²，Tianxia Wang^1,3，Xiaoyan Liu¹，Keisuke Hamada²，Dongxue Sun²，Yizheng Sun¹，Yanfang Yang¹，Jing Wang¹，Shogo Takahashi²，Qiong Wang²，Kristopher W.Krausz²，Changtao Jiang⁴，Cen Xie²，Xiuwei Yang¹，Frank J.Gonzalez²（State Key Laboratory of Natural and Biomimetic Drugs and Department of Natural Medicines，School of Pharmaceutical Sciences，Peking University；Laboratory of Metabolism，Center for Cancer Research，National Cancer Institute，National Institutes of Health；School of Life Science and Engineering，Lanzhou University of Technology；Department of Physiology and Pathophysiology，School of Basic Medical Sciences，Peking University，the Key Laboratory of Molecular Cardiovascular Science，Ministry of Education）.Crosstalk between CYP2E1 and PPARα substrates and agonists modulate adipose browning and obesity[J].Acta Pharmaceutica Sinica B,2022,第5期 Wei Shi^1,2,3，Wanzhen Li⁴，Jianxin Zhang⁴，Tiehai Li¹，Yakai Song¹，Yue Zeng¹，Qian Dong¹，Zeng Lin¹，Likun Gong¹，Shuquan Fan⁵，Feng Tang^1,2，Wei Huang^1,2,3,4（CAS Key Laboratory of Receptor Research，CAS Center for Excellence in Molecular Cell Science，Center for Biotherapeutics Discovery Research，Shanghai Institute of Materia Medica Chinese Academy of Sciences；School of Pharmaceutical Science and Technology，Hangzhou Institute of Advanced Study；University of Chinese Academy of Sciences；School of Chinese Materia Medica，Nanjing University of Chinese Medicine；School of Life Science，Liaocheng University）.One-step synthesis of site-specific antibody-drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates[J].Acta Pharmaceutica Sinica B,2022,第5期 Zhenlu Xu¹，Dongyun Liu²，Dong Liu²，Xue Ren³，Haibo Liu¹，Guihong Qi¹，Yue Zhou¹，Chongming Wu¹，Kui Zhu⁴，Zhongmei Zou¹，Jing Yuan³，Wenhan Lin²，Peng Guo^1,3（Pharmacology and Toxicology Research Center，Institute of Medicinal Plant Development，Chinese Academy of Medical Sciences，Peking Union Medical College；State Key Laboratory of Natural and Biomimetic Drugs，Peking University；Capital Institute of Pediatrics；National Center for Veterinary Drug Safety Evaluation，College of Veterinary Medicine，China Agricultural University）.Equisetin is an anti-obesity candidate through targeting 11β-HSD1[J].Acta Pharmaceutica Sinica B,2022,第5期 Elisa Rioja-Blanco^1,2，Irene Arroyo-Solera^1,2,3，Patricia álamo^1,2,3，Isolda Casanova^1,2,3，Alberto Gallardo^1,4，Ugutz Unzueta^1,2,3，Naroa Serna^3,5,6，Laura Sánchez-García^3,5,6，Miquel Quer^3,7，Antonio Villaverde^3,5,6，Esther Vázquez^3,5,6，Ramon Mangues^1,2,3，Lorena Alba-Castellón^1,2，Xavier León^3,7（Institut d'Investigació Biomèdica Sant Pau(IIB-Sant Pau) Institut de Recerca contra la Leucèmia Josep Carreras CIBER de Bioingeniería，Biomateriales y Nanomedicina(CIBER-BBN)；Department of Pathology，Hospital de la Santa Creu i Sant Pau；Institut de Biotecnologia i de Biomedicina，Universitat Autònoma de Barcelona；Departament de Genètica i de Microbiologia，Universitat Autònoma de Barcelona；Department of Otorhinolaryngology，Hospital de la Santa Creu i Sant Pau）.Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4⁺ head and neck squamous cell carcinoma tumors[J].Acta Pharmaceutica Sinica B,2022,第5期 Peihua Liu¹，Ling Jiang¹，Weimin Kong¹，Qiushi Xie¹，Ping Li¹，Xiaonan Liu¹，Jiayi Zhang¹，Ming Liu¹，Zhongjian Wang²，Liang Zhu¹，Hanyu Yang¹，Ying Zhou¹，Jianjun Zou³，Xiaodong Liu¹，Li Liu¹（Center of Drug Metabolism and Pharmacokinetics，School of Pharmacy，China Pharmaceutical University；Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy，Xuzhou Medical University；Department of Clinical Pharmacology，Nanjing First Hospital，Nanjing Medical University）.PXR activation impairs hepatic glucose metabolism partly via inhibiting the HNF4α-GLUT2 pathway[J].Acta Pharmaceutica Sinica B,2022,第5期 Nazi Song¹，Hongjiao Xu¹，Jiahua Liu^2,3,4，Qian Zhao¹，Hui Chen¹，Zhibin Yan^5,6，Runling Yang^5,6，Zhiteng Luo¹，Qi Liu⁷，Jianmei Ouyang⁷，Shuohan Wu¹，Suijia Luo⁷，Shuyin Ye⁷，Runfeng Lin¹，Xi Sun^2,3,4，Junqiu Xie^5,6，Tian Lan⁸，Zhongdao Wu^2,3,4，Rui Wang^5,6，Xianxing Jiang¹（School of Pharmaceutical Sciences，Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery，Sun Yat-sen University；Department of Parasitology of Zhongshan School of Medicine，Sun Yat-sen University；Key Laboratory of Tropical Disease Control，Ministry of Education，Sun Yat-sen University；Provincial Engineering Technology Research Center for Biological Vector Control，Sun Yat-sen University；Research Unit of Peptide Science，Chinese Academy of Medical Sciences；Key Laboratory of Preclinical Study for New Drugs of Gansu Province，School of Basic Medical Sciences，Lanzhou University；Shenzhen Turier Biotech.Co.，Ltd.；Guangdong Pharmaceutical University）.Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis[J].Acta Pharmaceutica Sinica B,2022,第5期 Wufa Fan¹，Haixia Peng¹，Zhou Yu¹，Luting Wang¹，Haisheng He¹，Yuhua Ma^1,2，Jianping Qi^1,3，Yi Lu^1,3，Wei Wu^1,4,3（Key Laboratory of Smart Drug Delivery of MOE，School of Pharmacy，Fudan University；Key Laboratory for Tibet Plateau Phytochemistry of Qinghai Province，School of Pharmacy，Qinghai Nationalities University；Shanghai Skin Disease Hospital，Tongji University School of Medicine；Center for Medical Research and Innovation，Shanghai Pudong Hospital，Fudan University Pudong Medical Center）.The long-circulating effect of pegylated nanoparticles revisited via simultaneous monitoring of both the drug payloads and nanocarriers[J].Acta Pharmaceutica Sinica B,2022,第5期 Zhuo-Xun Wu¹，Qiu-Xu Teng¹，Yuqi Yang¹，Nikita Acharekar¹，Jing-Quan Wang¹，Min He²，Sabesan Yoganathan¹，Jun Lin³，Jian Wang²，Zhe-Sheng Chen¹（Department of Pharmaceutical Sciences，College of Pharmacy and Health Sciences，St.John's University；Department of Radiotherapy，the Affiliated Jiangyin People's Hospital of Nantong University；Department of Anesthesiology，Stony Brook University Health Sciences Center）.MET inhibitor tepotinib antagonizes multidrug resistance mediated by ABCG2 transporter：In vitro and in vivo study[J].Acta Pharmaceutica Sinica B,2022,第5期 Qiuyi Li，Cheng Chen，Jinxia Kong，Lian Li，Junlin Li，Yuan Huang（Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province，Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology，West China School of Pharmacy，Sichuan University）.Stimuli-responsive nano vehicle enhances cancer immunotherapy by coordinating mitochondria-targeted immunogenic cell death and PD-L1 blockade[J].Acta Pharmaceutica Sinica B,2022,第5期 Gan Wang¹，Min Zhang^1,2，Ping Meng¹，Chengbo Long^1,2，Xiaodong Luo³，Xingwei Yang³，Yunfei Wang^1,4，Zhiye Zhang¹，James Mwangi^1,2,5，Peter Muiruri Kamau^1,2,5，Zhi Daic¹，Zunfu Ke⁶，Yi Zhang⁷，Wenlin Chen⁸，Xudong Zhao¹，Fei Ge⁹，Qiumin Lv^1,5，Mingqiang Rong^1,5，Dongsheng Li¹，Yang Jin¹⁰，Xia Sheng¹¹，Ren Lai^1,4,5,12（Key Laboratory of Animal Models and Human Disease Mechanisms，Chinese Academy of Sciences/Key Laboratory of Bioactive Peptides of Yunnan Province，KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases，National Resource Center for Non-Human Primates，Kunming Primate Research Center，and National Research Facility for Phenotypic & Genetic Analysis of Model Animals(Primate Facility)，Kunming Institute of Zoology；University of Chinese Academy of Sciences；State Key Laboratory of Phytochemistry and Plant Resources in West China，Kunming Institute of Botany，Chinese Academy of Sciences；Institutes for Drug Discovery and Development，Chinese Academy of Sciences；Sino-African Joint Research Center，Chinese Academy of Science；Department of Pathology，First Affiliated Hospital，Sun Yat-sen University；Department of Orthopaedic Surgery，First Affiliated Hospital of Zhengzhou University；Department of Breast Surgery，Third Affiliated Hospital of Kunming Medical University，Yunnan Cancer Center；Department of Breast Surgery，First Affiliated Hospital of Kunming Medical University；Department of Biosciences，University of Oslo；Key Laboratory of Environment and Health，Ministry of Education & Ministry of Environmental Protection，And State Key Laboratory of Environmental Health，School of Public Health，Tongji Medical College，Huazhong University of Science and Technology；Center for Biosafety Mega-Science，Chinese Academy of Sciences）.Anticarin-β shows a promising antiosteosarcoma effect by specifically inhibiting CCT4 to impair proteostasis[J].Acta Pharmaceutica Sinica B,2022,第5期 Weimin Yu^1,2，Gang Xu^3,4，Hui Chen¹，Li Xiao¹，Gang Liu^1,5，Pingping Hu¹，Siqi Li¹，Vivi Kasim⁶，Chunyu Zeng⁷，Xiaoyong Tong¹（School of Pharmaceutical Sciences，Chongqing University；Institute of Health Biological Chemical Medication，Chongqing Institute of Green and Intelligent Technology，Chinese Academy of Sciences；Institute of Medicine and Equipment for High Altitude Region，College of High Altitude Military Medicine，Army Medical University(Third Military Medical University)；Key Laboratory of High Altitude Medicine，People's Liberation Army；Henan Key Laboratory of Medical Tissue Regeneration，College of Basic Medical Sciences，Xinxiang Medical University；Key Laboratory of Biorheological Science and Technology，Ministry of Education，College of Bioengineering，Chongqing University；Department of Cardiology，Daping Hospital，Army Medical University(Third Military Medical University)）.The substitution of SERCA2 redox cysteine 674 promotes pulmonary vascular remodeling by activating IRE1α/XBP1s pathway[J].Acta Pharmaceutica Sinica B,2022,第5期 Weiyi Xia¹，Chao Li²，Qinjun Chen²，Jiancheng Huang¹，Zhenhao Zhao²，Peixin Liu²，Kai Xu¹，Lei Li¹，Fangyuan Hu¹，Shujie Zhang¹，Tao Sun²，Chen Jiang²，Chen Zhao¹（Department of Ophthalmology and Vision Science，Eye & ENT Hospital，Shanghai Medical School，Fudan University；Key Laboratory of Smart Drug Delivery，Ministry of Education，Department of Pharmaceutics，School of Pharmacy，Fudan University）.Intravenous route to choroidal neovascularization by macrophage-disguised nanocarriers for mTOR modulation[J].Acta Pharmaceutica Sinica B,2022,第5期 Hong Tan¹，Huali Wang²，Jinhu Ma²，Hui Deng³，Qinghua He⁴，Qiang Chen²，Qinglian Zhang³（The Research Institute of Qinghai-Tibet Plateau，Southwest Minzu University；State Key Laboratory of Biotherapy and Cancer Center，West China Hospital，Sichuan University，and Collaborative Innovation Center of Biotherapy；School of Laboratory Medicine，Chengdu Medical College；Key Laboratory of Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Utilization，Southwest Minzu University）.Identification of human LDHC4 as a potential target for anticancer drug discovery[J].Acta Pharmaceutica Sinica B,2022,第5期 Pedro Martín-Acosta¹，Qianli Meng¹，John Klimek¹，Ashok P.Reddy²，Larry David^1,3，Stefanie Kaech Petrie^3,4，Bingbing X.Li¹，Xiangshu Xiao^1,3（Program in Chemical Biology，Department of Chemical Physiology and Biochemistry，Oregon Health & Science University；Proteomics Shared Resource，Oregon Health & Science University；Knight Cancer Institute，Oregon Health & Science University；Department of Neurology，Oregon Health & Science University）.A clickable photoaffinity probe of betulinic acid identifies tropomyosin as a target[J].Acta Pharmaceutica Sinica B,2022,第5期 Abi Maharjan^1,2,3，Hongyu Sun^1,4，Zeying Cao^1,3，Ke Li^3,5，Jinping Liu⁶，Jun Liu^1,7，Tiqiao Xiao⁵，Guanyun Peng⁵，Junqiu Ji⁷，Peter York¹，Balmukunda Regmi⁸，Xianzhen Yin^1,7，Jiwen Zhang^1,3,4，Li Wu^1,2（Center for Drug Delivery System，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；School of Pharmacy，Key Laboratory of Molecular Pharmacology and Drug Evaluation，Ministry of Education，Yantai University；University of Chinese Academy of Sciences；NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients，National Institutes for Food and Drug Control；Shanghai Synchrotron Radiation Facility/Zhangjiang Lab，Shanghai Advanced Research Institute，Chinese Academy of Sciences；Hefei Lifeon Medication Group；Center for MOST and Image Fusion Analysis，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；Maharajgung Medical Campus，Institute of Medicine，Tribhuvan University）.Redefinition to bilayer osmotic pump tablets as subterranean river system within mini-earth via three-dimensional structure mechanism[J].Acta Pharmaceutica Sinica B,2022,第5期 Editoral Office of Acta Pharmaceutica Sinica（Editoral Office of Acta Pharmaceutica Sinica）.Information for Authors[J].Acta Pharmaceutica Sinica B,2022,第5期 Tengfei Xue¹，Juan Ji¹，Yuqin Sun¹，Xinxin Huang²，Zhenyu Cai¹，Jin Yang¹，Wei Guo¹，Ruobing Guo¹，Hong Cheng²，Xiulan Sun^1,3（Department of Pharmacology，Neuroprotective Drug Discovery Key Laboratory，Jiangsu Key Laboratory of Neurodegeneration，Nanjing Medical University；The First Affiliated Hospital of Nanjing Medical University；Nanjing University of Chinese Medicine，the Affiliated Hospital of Nanjing University of Chinese Medicine）.Sphingosine-1-phosphate, a novel TREM2 ligand, promotes microglial phagocytosis to protect against ischemic brain injury[J].Acta Pharmaceutica Sinica B,2022,第4期 Guangdi Li¹，Yali Wang¹，Erik De Clercq²（Hunan Provincial Key Laboratory of Clinical Epidemiology，Xiangya School of Public Health，Central South University；Rega Institute for Medical Research，Department of Microbiology，Immunology and Transplantation）.Approved HIV reverse transcriptase inhibitors in the past decade[J].Acta Pharmaceutica Sinica B,2022,第4期 Tiecheng Zhong，Wenxin Zhang，Hongjie Guo，Xiaohui Pan，Xi Chen，Qiaojun He，Bo Yang，Ling Ding（Zhejiang Province Key Laboratory of Anti-Cancer Drug Research，Institute of Pharmacology and Toxicology，College of Pharmaceutical Sciences，Zhejiang University）.The regulatory and modulatory roles of TRP family channels in malignant tumors and relevant therapeutic strategies[J].Acta Pharmaceutica Sinica B,2022,第4期 Lingxin Hou¹，Ying Zhang¹，Han Ju¹，Srinivasulu Cherukupalli¹，Ruifang Jia¹，Jian Zhang²，Bing Huang³，Arianna Loregian⁴，Xinyong Liu^1,5，Peng Zhan^1,5（Department of Medicinal Chemistry，Key Laboratory of Chemical Biology(Ministry of Education)，School of Pharmaceutical Sciences，Cheeloo College of Medicine，Shandong University；Institute of Medical Sciences，The Second Hospital，Cheeloo College of Medicine，Shandong University；Institute of Poultry Science，Shandong Academy of Agricultural Sciences；Department of Molecular Medicine，University of Padova；China-Belgium Collaborative Research Center for Innovative Antiviral Drugs of Shandong Province）.Contemporary medicinal chemistry strategies for the discovery and optimization of infiuenza inhibitors targeting vRNP constituent proteins[J].Acta Pharmaceutica Sinica B,2022,第4期 Lei Wu¹，Lingling Wang¹，Xi Liu¹，Yuli Bai¹，Ruinan Wu¹，Xiang Li¹，Yutong Mao¹，Ling Zhang²，Yongxiang Zheng³，Tao Gong¹，Zhirong Zhang¹，Yuan Huang¹（Key Laboratory of Drug Targeting and Drug Delivery System，Ministry of Education，West China School of Pharmacy，Sichuan University；Sichuan University，College of Polymer Science and Engineering；Sichuan University West China School of Pharmacy）.Milk-derived exosomes exhibit versatile effects for improved oral drug delivery[J].Acta Pharmaceutica Sinica B,2022,第4期 Pengcheng Wang^1,2,3，Guangyi Zeng^1,2,3，Yu Yan^1,3，Song-yang Zhang^1,3，Yongqiang Dong^1,3，Yangming Zhang^1,3，Xingzhong Zhang^1,3，Huiying Liu^1,3，Zhipeng Zhang⁴，Changtao Jiang^1,2,3，Yanli Pang⁵（Department of Physiology and Pathophysiology，School of Basic Medical Sciences，Peking University，Key Laboratory of Molecular Cardiovascular Science，Ministry of Education；Center of Basic Medical Research，Institute of Medical Innovation and Research，Peking University Third Hospital；Center for Obesity and Metabolic Disease Research，School of Basic Medical Sciences，Peking University；General Surgery Department，Peking University Third Hospital；Center for Reproductive Medicine，Department of Obstetrics and Gynecology，Peking University Third Hospital）.Disruption of adipocyte HIF-1α improves atherosclerosis through the inhibition of ceramide generation[J].Acta Pharmaceutica Sinica B,2022,第4期 Minyang Fu，Dandan Peng，Tianxia Lan，Yuquan Wei，Xiawei Wei（Laboratory of Aging Research and Cancer Drug Target，State Key Laboratory of Biotherapy，National Clinical Research Center for Geriatrics，West China Hospital，Sichuan University）.Multifunctional regulatory protein connective tissue growth factor（CTGF）：A potential therapeutic target for diverse diseases[J].Acta Pharmaceutica Sinica B,2022,第4期首页上一页 4 5 6 7 8 下一页尾页共有11页，转到页

期刊文章列表